THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM
Total 13F shares
132,623,961
Share change
-36,021,438
Total reported value
$98,181,827
Put/Call ratio
74%
Price per share
$0.74
Number of holders
143
Value change
-$35,237,991
Number of buys
67
Number of sells
56

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q3 2021

As of 30 Sep 2021, THERAPEUTICSMD INC - COM (TXMD) was held by 143 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 132,623,961 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, FMR LLC, MORGAN STANLEY, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, C WorldWide Group Holding A/S, Rubric Capital Management LP, AMERIPRISE FINANCIAL INC, and NORTHERN TRUST CORP. This page lists 143 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.